Oil Edges Lower as Trump Moves to Ban Investors From Buying Homes | The Close 1/7/2026

Key Concepts

• Policy-Driven Market Volatility: President Trump’s statements and potential policy changes significantly impacted market performance, often overshadowing economic data.
• Housing Affordability Debate: A proposed ban on institutional investment in single-family homes sparked debate, with arguments centering on the true drivers of affordability and the role of institutional investors.
• Nutrition Guideline Updates: The FDA announced revised US nutrition guidelines emphasizing increased protein intake and reduced consumption of ultra-processed foods and added sugars.
• Flu Season & Vaccine Challenges: The current flu season is experiencing high incidence, highlighting the ongoing challenges of vaccine efficacy due to viral mutation.

Market Reactions & Political Influence

The day’s trading was heavily influenced by policy announcements and social media posts from President Trump. The S&P 500 closed down 0.3%, the Dow Jones lost 466 points (-0.9%), while the NASDAQ Composite gained slightly (+0.2%). Initial optimism regarding a Venezuela oil deal, boosting oil refiner stocks like Valero, was offset by concerns stemming from Washington. Trump threatened restrictions on dividends and stock buybacks for defense contractors, causing declines in Lockheed Martin (down nearly 5%), RTX (down 2.5% after-hours), and Raytheon (an additional 2% after-hours following a specific call-out on Truth Social). He also signaled a potential ban on institutional investors purchasing single-family homes, leading to a 5.6% drop in Blackstone shares and impacting companies like American Homes 4 Rent and LGI Homes. Defense stocks rebounded in after-hours trading following Trump’s announcement of a potential 50% increase in the military budget to $800 billion. Kraft Heinz also saw a 2% drop due to updated US nutrition guidelines. Intel’s 11% gain stood out as a positive outlier, driven by news related to humanoid robots. The prevailing market dynamic was described as “Washington rather than Wall Street wagging the dog.”

Housing Affordability & Institutional Investment

Trump’s proposal to ban institutional investors from the single-family home market dominated much of the discussion. Sean Dobson, CEO of Amherst, argued the ban would not improve affordability, attributing the crisis to rising mortgage rates (from 3% to 7%) and a 15% increase in government spending alongside a 30% rise in housing costs. He stated his company serves 200,000 people who would otherwise have limited housing options. He characterized the proposal as a politically motivated “scapegoat” that would “chill capital formation.” Institutional investors currently represent a relatively small fraction (1-10%) of single-family home ownership, and Federal Reserve studies suggest their impact on affordability is minimal. Dobson noted the increasing difficulty of obtaining mortgages, requiring high FICO scores and large down payments. He indicated previous agreement with policymakers on the issue until recently, attributing the shift to midterm election politics. Darrin Williams, CEO of Severn Bancorp (a CDFI), emphasized the role of CDFIs in providing mortgages to lower and middle-income individuals, highlighting a program assisting 500 families with an average home price of $280,000 in the Southern US, identifying down payments as a major barrier.

Nutrition Guidelines & Health

The FDA announced updated US nutrition guidelines, increasing the recommended protein intake by 50-100% and prioritizing the reduction of ultra-processed foods and added sugars. The new guidelines feature an “inverted food pyramid” prioritizing red meat and healthy fats. Dr. Makary criticized past recommendations promoting low-fat foods with added sugar and highlighted the link between ultra-processed foods and chronic diseases. He stated, “Today’s new nutrition guidance increases the protein recommendation by 50% to 100%. It should not be at a level so you don't wither away. We want Americans to thrive.”

Flu Season & Vaccine Efficacy

The current flu season is experiencing its highest incidence in five years. Dr. Makary acknowledged the challenges of vaccine efficacy due to the influenza virus’s rapid mutation rate (35 times faster than COVID). He advocated for the development of a “universal flu shot” offering broader and longer-lasting protection. He clarified that there were no scientific reviewer layoffs at the FDA, attributing staffing changes to IT and HR consolidation.

Conclusion

The segment highlighted the significant influence of political factors on market performance, particularly through President Trump’s statements and potential policy changes. The debate surrounding housing affordability underscored the complexity of the issue and challenged the narrative blaming institutional investors. Updates to nutrition guidelines and discussions on flu season efficacy demonstrated a broader focus on public health and well-being. Overall, the segment emphasized a volatile market environment driven by policy uncertainty and the ongoing challenges of addressing complex societal issues.